Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis [Yahoo! Finance]
Surrozen, Inc. (SRZN)
Company Research
Source: Yahoo! Finance
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced a strategic research collaboration with privately-held TCGFB, Inc. (“TCGFB”) to discover antibody therapeutics targeting Transforming Growth Factor Beta (TGF-ß) for the potential treatment of patients with idiopathic pulmonary fibrosis (IPF). Under the terms of the agreement, Surrozen will provide antibody discovery services for a period of up to two years. TCGFB will own all TGF-ß product related intellectual property. In exchange for Surrozen's research services, TCGFB will pay Surrozen up to $6 million in the aggregate, plus any third-party costs, and will issue Surrozen a warrant for up to 3,380,000 shares of TCGFB common stock at an exercise price of $0.0001 per share based on certain vesting conditions. “We are excite
Show less
Read more
Impact Snapshot
Event Time:
SRZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRZN alerts
High impacting Surrozen, Inc. news events
Weekly update
A roundup of the hottest topics
SRZN
News
- Surrozen to Present at Upcoming Healthcare Investor ConferencesGlobeNewswire
- Surrozen Provides Third Quarter 2024 Financial Results and Business UpdateGlobeNewswire
- Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary FibrosisGlobeNewswire
- Surrozen earns $10M milestone payment through Boehringer collaboration [Seeking Alpha]Seeking Alpha
- Surrozen Earns $10 Million Milestone Payment in Retinal Diseases CollaborationGlobeNewswire
SRZN
Earnings
- 5/8/24 - Beat
SRZN
Sec Filings
- 11/14/24 - Form SCHEDULE
- 11/14/24 - Form SCHEDULE
- 11/14/24 - Form SC
- SRZN's page on the SEC website